Comparative Pharmacology
Head-to-head clinical analysis: DICURIN PROCAINE versus MODURETIC 5 50.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DICURIN PROCAINE versus MODURETIC 5 50.
DICURIN PROCAINE vs MODURETIC 5-50
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dicurin Procaine is a mercurial diuretic that inhibits sodium and chloride reabsorption in the proximal tubule and loop of Henle, leading to increased urine output. The procaine component provides local anesthetic effects.
Combination diuretic: amiloride blocks epithelial sodium channels (ENaC) in distal tubule, inhibiting sodium reabsorption and potassium excretion; hydrochlorothiazide inhibits sodium-chloride symporter in distal convoluted tubule, increasing sodium, chloride, and water excretion.
50-100 mg (as procaine penicillin G) intramuscularly once daily; severe infections: 100-200 mg IM every 12-24 hours.
1 tablet (5 mg amiloride/50 mg hydrochlorothiazide) orally once daily, increased if needed to 2 tablets daily as a single dose or divided doses.
None Documented
None Documented
Terminal elimination half-life: 0.5-1.5 hours (short-acting local anesthetic). Clinically, repeated doses may lead to accumulation if hepatic or renal impairment exists.
HCTZ: 5.6-14.8 hours; amiloride: 6-9 hours. Both prolonged in renal impairment (e.g., creatinine clearance <30 mL/min). Terminal elimination half-life for HCTZ may extend to >20 hours in severe renal disease.
Renal excretion of unchanged drug and metabolites: 60-80% via glomerular filtration and tubular secretion; biliary excretion <5%.
Both components are primarily excreted renally: hydrochlorothiazide (HCTZ) ~70% unchanged in urine; amiloride ~50% unchanged in urine. Minor biliary/fecal elimination (<10% for each).
Category C
Category C
Diuretic
Diuretic